IRON CHELATORS IN MEDICINE

被引：37
作者：
HERSHKO, C [1 ]
机构：
[1] SHAARE ZEDEK MED CTR, DEPT MED, JERUSALEM, ISRAEL
来源：
MOLECULAR ASPECTS OF MEDICINE | 1992年 / 13卷 / 02期
关键词：
D O I：
10.1016/0098-2997(92)90013-P
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：113 / 165
页数：53
相关论文
共 201 条
[11]  
BARRY M, 1974, BRIT J HAEMATOL, V76, P301
[12]  
BATEY RG, 1978, CLIN SCI MOL MED, V55, pP24
[13]   COMPARISON OF DEFEROXAMINE PHARMACOKINETICS BETWEEN ASYMPTOMATIC THALASSEMIC CHILDREN AND THOSE EXHIBITING SEVERE NEUROTOXICITY [J].
BENTUR, Y ;
KOREN, G ;
TESORO, A ;
CARLEY, H ;
OLIVIERI, N ;
FREEDMAN, MH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (04) :478-482
[14]  
BERNARD M, 1988, CIRCULATION, V78, P164
[15]   EFFECT OF METAL CHELATORS AND ANTI-INFLAMMATORY DRUGS ON THE DEGRADATION OF HYALURONIC-ACID [J].
BETTS, WH ;
CLELAND, LG .
ARTHRITIS AND RHEUMATISM, 1982, 25 (12) :1469-1476
[16]  
BLAKE DR, 1981, LANCET, V2, P1142
[17]  
BLAKE DR, 1985, Q J MED, V56, P345
[18]   EFFECT OF A SPECIFIC IRON CHELATING AGENT ON ANIMAL-MODELS OF INFLAMMATION [J].
BLAKE, DR ;
HALL, ND ;
BACON, PA ;
DIEPPE, PA ;
HALLIWELL, B ;
GUTTERIDGE, JMC .
ANNALS OF THE RHEUMATIC DISEASES, 1983, 42 (01) :89-93
[19]  
BLATT J, 1988, J LAB CLIN MED, V112, P433
[20]  
BLATT J, 1987, CANCER RES, V47, P1749
12345678910